Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response.
Nora DrickBenjamin SeeligerTobias WelteJan FugeHendrik SuhlingPublished in: BMC pulmonary medicine (2018)
Using improvement of lung function, decrease of eosinophils and improvement of subjective condition as response criteria, 76% of treated patients could be classified as treatment responders, demonstrating the efficacy of anti-IL-5 therapy in clinical practice.
Keyphrases
- lung function
- chronic obstructive pulmonary disease
- clinical practice
- newly diagnosed
- cystic fibrosis
- end stage renal disease
- air pollution
- ejection fraction
- chronic kidney disease
- prognostic factors
- stem cells
- physical activity
- depressive symptoms
- patient reported outcomes
- combination therapy
- drug induced
- smoking cessation